FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3044188507> ?p ?o ?g. }

• W3044188507 endingPage "381" @default.
• W3044188507 startingPage "381" @default.
• W3044188507 abstract "Tenofovir disoproxil fumarate (TDF)-induced nephrotoxicity is related to high plasma tenofovir concentrations. Tenofovir alafenamide (TAF) is a tenofovir prodrug with 90% lower plasma tenofovir concentrations. The aim of this study was to evaluate changes in tenofovir-induced nephrotoxicity in Human Immunodeficiency Virus (HIV)-positive patients who switched from TDF to TAF.We identified all HIV-positive patients who switched from elvitegravir/cobicistat/emtricitabine/TDF to elvitegravir/cobicistat/emtricitabine/TAF at a tertiary hospital. We assessed tubulopathy and renal dysfunction before TDF administration, at the time TAF was used following at least 3 months of TDF use, and 3 months after TAF administration. Tubulopathy was defined by the presence of at least three abnormalities in fractional excretion of phosphate, fractional excretion of uric acid, urinary β2-microglobulin, urinary N-acetyl-β-D-glucosaminidase, glucosuria or proteinuria. Renal dysfunction was defined as decreased by more than 25% in the estimated glomerular filtration rate (eGFR) relative to baseline.In 80 patients, the mean eGFR was 96.8 mL/min/1.73 m² before administration of TDF, 81.2 (P <0.001) at the time of change to TAF, 90.9 (P <0.001) after TAF administration. Renal dysfunction occurred in 19 patients (23.8%) after TDF use for a median 15 months, 11 (57.9%) of these patients recovered from renal dysfunction after TAF administration. Six patients (7.5%) had tubulopathy before TDF administration, 36 (45.0%) after TDF administration (P <0.001), 12 (15.0%) after TAF administration (P = 0.002).Tenofovir-induced nephrotoxicity in HIV-positive patients receiving TDF was mostly reversible after changing to TAF. Thus, TAF-containing regimens can be administered safely to HIV-positive patients with tenofovir-induced nephrotoxicity." @default.
• W3044188507 created "2020-07-29" @default.
• W3044188507 creator A5000692587 @default.
• W3044188507 creator A5026549320 @default.
• W3044188507 creator A5039627231 @default.
• W3044188507 creator A5042580585 @default.
• W3044188507 creator A5043343344 @default.
• W3044188507 creator A5047389804 @default.
• W3044188507 creator A5056705380 @default.
• W3044188507 creator A5063884420 @default.
• W3044188507 creator A5081894061 @default.
• W3044188507 creator A5084300952 @default.
• W3044188507 creator A5088165965 @default.
• W3044188507 creator A5091220568 @default.
• W3044188507 date "2020-01-01" @default.
• W3044188507 modified "2023-10-06" @default.
• W3044188507 title "Recovery of Tenofovir-induced Nephrotoxicity following Switch from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in Human Immunodeficiency Virus-Positive Patients" @default.
• W3044188507 cites W1971643795 @default.
• W3044188507 cites W1990951677 @default.
• W3044188507 cites W1992392338 @default.
• W3044188507 cites W2007801453 @default.
• W3044188507 cites W2017605567 @default.
• W3044188507 cites W2053407562 @default.
• W3044188507 cites W2055483238 @default.
• W3044188507 cites W2091989309 @default.
• W3044188507 cites W2093735312 @default.
• W3044188507 cites W2095607708 @default.
• W3044188507 cites W2102661607 @default.
• W3044188507 cites W2126268386 @default.
• W3044188507 cites W2148750104 @default.
• W3044188507 cites W2149185709 @default.
• W3044188507 cites W2153548254 @default.
• W3044188507 cites W2162761942 @default.
• W3044188507 cites W2186174256 @default.
• W3044188507 cites W2291890939 @default.
• W3044188507 cites W2319917590 @default.
• W3044188507 cites W2327535499 @default.
• W3044188507 cites W2602129283 @default.
• W3044188507 cites W2773911224 @default.
• W3044188507 cites W2791745392 @default.
• W3044188507 cites W2902998614 @default.
• W3044188507 cites W4238444439 @default.
• W3044188507 cites W4240243247 @default.
• W3044188507 doi "https://doi.org/10.3947/ic.2020.52.3.381" @default.
• W3044188507 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7533205" @default.
• W3044188507 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32757496" @default.
• W3044188507 hasPublicationYear "2020" @default.
• W3044188507 type Work @default.
• W3044188507 sameAs 3044188507 @default.
• W3044188507 citedByCount "7" @default.
• W3044188507 countsByYear W30441885072021 @default.
• W3044188507 countsByYear W30441885072023 @default.
• W3044188507 crossrefType "journal-article" @default.
• W3044188507 hasAuthorship W3044188507A5000692587 @default.
• W3044188507 hasAuthorship W3044188507A5026549320 @default.
• W3044188507 hasAuthorship W3044188507A5039627231 @default.
• W3044188507 hasAuthorship W3044188507A5042580585 @default.
• W3044188507 hasAuthorship W3044188507A5043343344 @default.
• W3044188507 hasAuthorship W3044188507A5047389804 @default.
• W3044188507 hasAuthorship W3044188507A5056705380 @default.
• W3044188507 hasAuthorship W3044188507A5063884420 @default.
• W3044188507 hasAuthorship W3044188507A5081894061 @default.
• W3044188507 hasAuthorship W3044188507A5084300952 @default.
• W3044188507 hasAuthorship W3044188507A5088165965 @default.
• W3044188507 hasAuthorship W3044188507A5091220568 @default.
• W3044188507 hasBestOaLocation W30441885071 @default.
• W3044188507 hasConcept C126189478 @default.
• W3044188507 hasConcept C126322002 @default.
• W3044188507 hasConcept C126894567 @default.
• W3044188507 hasConcept C142462285 @default.
• W3044188507 hasConcept C159047783 @default.
• W3044188507 hasConcept C159641895 @default.
• W3044188507 hasConcept C2777068322 @default.
• W3044188507 hasConcept C2778573388 @default.
• W3044188507 hasConcept C2779026464 @default.
• W3044188507 hasConcept C2779561371 @default.
• W3044188507 hasConcept C2779778239 @default.
• W3044188507 hasConcept C2780091579 @default.
• W3044188507 hasConcept C2780524789 @default.
• W3044188507 hasConcept C2911190787 @default.
• W3044188507 hasConcept C2993143319 @default.
• W3044188507 hasConcept C3013748606 @default.
• W3044188507 hasConcept C71924100 @default.
• W3044188507 hasConcept C90924648 @default.
• W3044188507 hasConcept C98274493 @default.
• W3044188507 hasConceptScore W3044188507C126189478 @default.
• W3044188507 hasConceptScore W3044188507C126322002 @default.
• W3044188507 hasConceptScore W3044188507C126894567 @default.
• W3044188507 hasConceptScore W3044188507C142462285 @default.
• W3044188507 hasConceptScore W3044188507C159047783 @default.
• W3044188507 hasConceptScore W3044188507C159641895 @default.
• W3044188507 hasConceptScore W3044188507C2777068322 @default.
• W3044188507 hasConceptScore W3044188507C2778573388 @default.
• W3044188507 hasConceptScore W3044188507C2779026464 @default.
• W3044188507 hasConceptScore W3044188507C2779561371 @default.
• W3044188507 hasConceptScore W3044188507C2779778239 @default.
• W3044188507 hasConceptScore W3044188507C2780091579 @default.
• W3044188507 hasConceptScore W3044188507C2780524789 @default.

• next